Page last updated: 2024-08-22

ruthenium and Lymphoma

ruthenium has been researched along with Lymphoma in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dixit, D; Dubey, SK; Koiri, RK; Mishra, L; Pandey, K; Trigun, SK	1
Bergamo, A; Capozzi, I; Clerici, K; Cocchietto, M; Salerno, G; Sava, G	1

Other Studies

2 other study(ies) available for ruthenium and Lymphoma

Article	Year
Regression of Dalton's lymphoma in vivo via decline in lactate dehydrogenase and induction of apoptosis by a ruthenium(II)-complex containing 4-carboxy N-ethylbenzamide as ligand. Investigational new drugs, 2009, Volume: 27, Issue:6 Topics: Alanine Transaminase; Animals; Apoptosis; Ascitic Fluid; Aspartate Aminotransferases; Benzamides; Cell Death; Cell Line, Tumor; Cisplatin; Coordination Complexes; DNA Fragmentation; Isoenzymes; L-Lactate Dehydrogenase; Ligands; Lymphoma; Mice; Remission Induction; Ruthenium; Survival Analysis	2009
Modification of cell cycle and viability of TLX5 lymphoma in vitro by sulfoxide-ruthenium compounds and cisplatin detected by flow cytometry. Chemico-biological interactions, 1998, May-01, Volume: 113, Issue:1 Topics: Animals; Antineoplastic Agents; Bromodeoxyuridine; Cell Cycle; Cell Survival; Cisplatin; Dimethyl Sulfoxide; DNA, Neoplasm; Doxorubicin; Flow Cytometry; In Vitro Techniques; Lung Neoplasms; Lymphoma; Mice; Mice, Inbred CBA; Organometallic Compounds; Ruthenium; Tumor Cells, Cultured	1998

Article

Year

Regression of Dalton's lymphoma in vivo via decline in lactate dehydrogenase and induction of apoptosis by a ruthenium(II)-complex containing 4-carboxy N-ethylbenzamide as ligand.

Investigational new drugs, 2009, Volume: 27, Issue:6

Topics: Alanine Transaminase; Animals; Apoptosis; Ascitic Fluid; Aspartate Aminotransferases; Benzamides; Cell Death; Cell Line, Tumor; Cisplatin; Coordination Complexes; DNA Fragmentation; Isoenzymes; L-Lactate Dehydrogenase; Ligands; Lymphoma; Mice; Remission Induction; Ruthenium; Survival Analysis

2009

Modification of cell cycle and viability of TLX5 lymphoma in vitro by sulfoxide-ruthenium compounds and cisplatin detected by flow cytometry.

Chemico-biological interactions, 1998, May-01, Volume: 113, Issue:1

Topics: Animals; Antineoplastic Agents; Bromodeoxyuridine; Cell Cycle; Cell Survival; Cisplatin; Dimethyl Sulfoxide; DNA, Neoplasm; Doxorubicin; Flow Cytometry; In Vitro Techniques; Lung Neoplasms; Lymphoma; Mice; Mice, Inbred CBA; Organometallic Compounds; Ruthenium; Tumor Cells, Cultured

1998